Glutamate dehydrogenase

Source: Wikipedia, the free encyclopedia.
glutamate dehydrogenase (GLDH)
Identifiers
ExPASy
NiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins
glutamate dehydrogenase [NAD(P)+]
Identifiers
ExPASy
NiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins
glutamate dehydrogenase (NADP+)
Identifiers
ExPASy
NiceZyme view
KEGGKEGG entry
MetaCycmetabolic pathway
PRIAMprofile
PDB structuresRCSB PDB PDBe PDBsum
Gene OntologyAmiGO / QuickGO
Search
PMCarticles
PubMedarticles
NCBIproteins

Glutamate dehydrogenase (GLDH, GDH) is an

Michaelis constant
of about 1 mM), and therefore toxic levels of ammonia would have to be present in the body for the reverse reaction to proceed (that is, α-ketoglutarate and ammonia to glutamate and NAD(P)+). However, in brain, the NAD+/NADH ratio in brain mitochondria encourages oxidative deamination (i.e. glutamate to α-ketoglutarate and ammonia).[1] In bacteria, the ammonia is assimilated to amino acids via glutamate and aminotransferases.[2] In plants, the enzyme can work in either direction depending on environment and stress.[3][4] Transgenic plants expressing microbial GLDHs are improved in tolerance to herbicide, water deficit, and pathogen infections.[5] They are more nutritionally valuable.[6]

The enzyme represents a key link between

catabolic and anabolic pathways, and is, therefore, ubiquitous in eukaryotes. In humans the relevant genes are called GLUD1 (glutamate dehydrogenase 1) and GLUD2 (glutamate dehydrogenase 2), and there are also at least 8 GLDH pseudogenes in the human genome
as well, probably reflecting microbial influences on eukaryote evolution.

  • Glutamate
    Glutamate
  • α-Ketoglutarate
    α-Ketoglutarate

Clinical application

GLDH can be measured in a

clinical trials, GLDH can serve as a measurement for the safety of a drug.[citation needed
]

Enzyme immunoassay (EIA) for glutamate dehydrogenase (GDH) can be used as screening tool for patients with Clostridioides difficile infection. The enzyme is expressed constitutively by most strains of C.diff, and can thus be easily detected in stool. Diagnosis is generally confirmed with a follow-up EIA for C. Diff toxins A and B.[citation needed]

Cofactors

NADP+) is a cofactor for the glutamate dehydrogenase reaction, producing α-ketoglutarate and ammonium as a byproduct.[4][7]

Based on which cofactor is used, glutamate dehydrogenase enzymes are divided into the following three classes:[citation needed]

  • EC 1.4.1.2: L-glutamate + H2O + NAD+ 2-oxoglutarate + NH3 + NADH + H+
  • EC 1.4.1.3: L-glutamate + H2O + NAD(P)+ 2-oxoglutarate + NH3 + NAD(P)H + H+
  • EC 1.4.1.4: L-glutamate + H2O + NADP+ 2-oxoglutarate + NH3 + NADPH + H+

Role in flow of nitrogen

Ammonia incorporation in animals and microbes occurs through the actions of glutamate dehydrogenase and

mammalian and microbe nitrogen flow, serving as both a nitrogen donor and a nitrogen acceptor.[citation needed
]

Regulation of glutamate dehydrogenase

In humans, the activity of glutamate dehydrogenase is controlled through

blood glucose. Under these circumstances, glutamate dehydrogenase activity is raised in order to increase the amount of α-ketoglutarate produced, which can be used to provide energy by being used in the citric acid cycle to ultimately produce ATP.[citation needed
]

In microbes, the activity is controlled by the concentration of ammonium and or the like-sized rubidium ion, which binds to an allosteric site on GLDH and changes the Km (

Michaelis constant) of the enzyme.[8]

The control of GLDH through ADP-ribosylation is particularly important in

β cells. Beta cells secrete insulin in response to an increase in the ATP:ADP ratio, and, as amino acids are broken down by GLDH into α-ketoglutarate, this ratio rises and more insulin is secreted. SIRT4 is necessary to regulate the metabolism of amino acids as a method of controlling insulin secretion and regulating blood glucose
levels.

Bovine liver glutamate dehydrogenase was found to be regulated by nucleotides in the late 1950s and early 1960s by Carl Frieden.[9] [10] [11] [12] In addition to describing the effects of nucleotides like ADP, ATP and GTP he described in detail the different kinetic behavior of NADH and NADPH. As such it was one of the earliest enzymes to show what was later described as allosteric behavior. [13]

The activation of mammalian GDH by L-leucine and some other hydrophobic amino acids has also been long known,[14] however localization of the binding site was not clear. Only recently the new allosteric binding site for L-leucine was identified in a mammalian enzyme.[15]

Mutations which alter the allosteric binding site of GTP cause permanent activation of glutamate dehydrogenase, and lead to hyperinsulinism-hyperammonemia syndrome.

Regulation

Allosteric regulation:

This protein may use the morpheein model of allosteric regulation.[7][16]

Allosteric inhibitors:

Activators:

Other Inhibitors:

Additionally, Mice GLDH shows substrate inhibition by which GLDH activity decreases at high glutamate concentrations.[7]

Isozymes

Humans express the following glutamate dehydrogenase isozymes:

Chr. 10 q21.1-24.3
Search for
StructuresSwiss-model
DomainsInterPro
Chr. X q25
Search for
StructuresSwiss-model
DomainsInterPro

See also

References

External links